Bio Pharma Dive
APRIL 3, 2025
The Swiss drugmaker, which holds European rights to Elevidys, suspended three trials while researchers investigate the death of a young man who died following treatment.
XTalks
APRIL 3, 2025
European AI med tech company AZmed received two new FDA clearances for its AI-powered chest X-ray tool, AZchest. The FDA approved AZchest applications to detect lung nodules and triage cases involving pneumothorax and pleural effusion. The applications offer radiologists improved interpretation and detection of these chest X-ray abnormalities. AZchest, a clinically validated AI radiology solution, automatically identifies, classifies and generates reports on key cardiac and pulmonary abnormaliti
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 3, 2025
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter Marks.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 3, 2025
The Kerala based Ayurveda Medicine Manufacturers Organisation of India (AMMOI) has got a chair in the administrative committee of the Ayush Export Promotion Council (Ayushexcil ) with the election of its general secretary Dr. D Ramanathan as one of the board of directors.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
APRIL 3, 2025
More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a strategic shift.
XTalks
APRIL 3, 2025
Eli Lilly shared new Phase II trial data showing that its experimental siRNA therapy, lepodisiran, leads to reductions in levels of lipoprotein(a) (Lp(a)) a genetically inherited risk factor for heart disease in adults with elevated levels of the marker. In the Phase II ALPACA trial, a single 400 mg dose of lepodisiran led to an average decrease of 93.9% in Lp(a) levels over the 60- to 180-day period after treatment compared to placebo, meeting the trials primary endpoint.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Intouch Solutions
APRIL 3, 2025
Artificial Intelligence (AI) is revolutionizing various industries, and pharma is no exception. However, despite its potential, more than half (55%) of pharma brand planning executives are concerned about their companys digital capabilities, especially generative AI. A recent article from Marketing & Pharma highlights the findings from EVERSANAs third-annual brand planning survey and the role AI plays in brand planning.
Pharmaceutical Technology
APRIL 3, 2025
If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to one day.
pharmaphorum
APRIL 3, 2025
Germany has agreed to reimburse CSL Behring's haemophilia B gene therapy Hemgenix with a unique outcomes-based payment model
Pharmaceutical Technology
APRIL 3, 2025
Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant epilepsy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
APRIL 3, 2025
Collaboration introduces automation to enhance efficiency
Pharmaceutical Technology
APRIL 3, 2025
Atsena Therapeutics has completed an oversubscribed Series C financing round, raising $150m to support the advancement of ATSN-201.
pharmaphorum
APRIL 3, 2025
BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class
Pharmaceutical Technology
APRIL 3, 2025
UK Government drug sale clawbacks must be eased for pharma innovation to meet its ten-year plan, say industry representatives.
pharmaphorum
APRIL 3, 2025
Novartis has claimed accelerated approval in the US for Vanrafia, one of a trio of drugs it hopes will revolutionise the treatment of IgA nephropathy.
Pharmaceutical Technology
APRIL 3, 2025
Reduced frequency is very encouraging for patient compliance and could help those who dislike weekly injections and self-administration.
Pharmaceutical Commerce
APRIL 3, 2025
In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, describes the various conference sessions that she participated in.
Pharmaceutical Technology
APRIL 3, 2025
Astellas Pharma has entered a strategic partnership with the JFCR to expedite research in translational and clinical oncology.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Commerce
APRIL 3, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirsts chief medical officer, explains the rise in patients turning to DTC platforms following insurance denials.
Pharmaceutical Technology
APRIL 3, 2025
Thin-layer chromatography (TLC) is a valuable tool, particularly in the analysis of herbal medicines and traditional remedies.
Pharmaceutical Commerce
APRIL 3, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
APRIL 3, 2025
The FDA has granted accelerated approval to Novartis Vanrafia for adults with primary immunoglobulin A nephropathy (IgAN).
pharmaphorum
APRIL 3, 2025
Three studies of Sarepta's Elevidys Duchenne gene therapy have been placed on hold as the death of a 16-year-old boy is investigated
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 3, 2025
(Mehau Kulyk/SPL/Getty Images) Nearly two decades after suffering a brainstem stroke at the age of 30 that left her unable to speak, a woman in the US regained the ability to turn her thoughts into words in real time thanks to a new brain-computer interface (BCI) process.
Pharmaceutical Technology
APRIL 3, 2025
Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment.
Rethinking Clinical Trials
APRIL 3, 2025
Speakers Anivarya Kumar, BA Fourth-Year Medical Student Duke University School of Medicine Matthew Engelhard, MD, PhD Assistant Professor, Department of Biostatistics & Bioinformatics Duke University School of Medicine Slides Keywords Health Literacy; Large Language Models; Artificial Intelligence; Electronic Health Records Key Points Limited health literacy (HL) has tangible effects on morbidity and mortality: its associated with higher rates of hospital admissions a
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 3, 2025
Indian pharmaceutical sector demands a highly skilled workforce proficient in technology, data science, and regulatory compliance. This is because as the global pharma and life sciences landscape evolves rapidly, hiring trends and talent retention strategies have emerged as key priorities.
Pharma Times
APRIL 3, 2025
Approval extends ustekinumabs use to younger patients
FDA Law Blog
APRIL 3, 2025
By John W.M. Claud & JP Ellison Last June, the United States Supreme Court issued four landmark decisions that curbed executive agency powers. Those decisions are changing the way agencies, including FDA, exercise their rulemaking and enforcement authorities. Regardless your position on the correctness of the holdings or the reasoning behind them, Loper Bright , Jarkesy , EPA v.
Bio Pharma Dive
APRIL 3, 2025
Mehmet Oz, a physician and TV personality, takes office as HHS lays off thousands of staffers and Republicans float potential cuts to Medicaid.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
276 
Let's personalize your content